Kia Begins Building 250,000-Unit PBV Production Hub with New EVO Plant Complex in Hwaseong

COMPANY / Reporter Kim Jisun / 2025-11-14 14:32:23

A view of Hyundai Motor Group’s Autoland Hwaseong plant in Ujeong-eup, Hwaseong, Gyeonggi Province. 

(Photo courtesy of Hyundai Motor Group)

 

 

[Alpha Biz= Paul Lee] SEOUL, November 14 — Kia announced that it has begun establishing a purpose-built vehicle (PBV) production hub capable of producing 250,000 units annually, anchored by its new PBV-dedicated EVO Plant in Hwaseong.


The company held the completion ceremony for EVO Plant East and the groundbreaking ceremony for EVO Plant West at Autoland Hwaseong in Ujeong-eup, Hwaseong, Gyeonggi Province.


The event was attended by Prime Minister Kim Min-seok, First Vice Minister of Trade, Industry and Energy Moon Shin-hak, Gyeonggi Governor Kim Dong-yeon, Hwaseong Mayor Jeong Myeong-geun, Hyundai Motor Group Executive Chair Euisun Chung, and approximately 200 government officials and company executives.


Kia has secured a 300,375 m² site—equivalent to 42 football fields—for EVO Plant East, EVO Plant West (scheduled to begin operations in 2027), and a PBV Conversion Center. The company plans to invest around KRW 4 trillion in facilities and R&D.


Kia will also utilize approximately 105,000 pyeong of idle state-owned land within Autoland Hwaseong to build a 50 MW solar power plant, accelerating its efforts to achieve RE100 through the use of 100% renewable energy.

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

Samsung Electronics to Cancel KRW 14.6 Trillion Treasury Shares to Boost Shareholder Value
Bithumb Reports 52% Drop in Net Profit Despite Revenue and Operating Gains
Hanwha Vice Chairman Kim Dong-kwan Receives KRW 50 Billion Dividend from Hanwha Energy Ahead of Rights Issue Backlash
HS Hyosung Advanced Materials to Acquire 66.7% Stake in Belgian Battery Materials Firm for KRW 104 Billion
Hyundai GF Holdings to Complete KRW 350 Billion Treasury Share Cancellation by First Half
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS